Literature DB >> 29935652

Using observational data for personalized medicine when clinical trial evidence is limited.

Boris Gershman1, David P Guo2, Issa J Dahabreh3.   

Abstract

Randomized clinical trials are considered the preferred approach for comparing the effects of treatments, yet data from high-quality clinical trials are often unavailable and many clinical decisions are made on the basis of evidence from observational studies. Using clinical examples about the management of infertility, we discuss how we can use observational data from large and information-rich health-care databases combined with modern epidemiological and statistical methods to learn about the effects of interventions when clinical trial evidence is unavailable or not applicable to the clinically relevant target population. When trial evidence is unavailable, we can conduct observational analyses emulating the hypothetical pragmatic target trials that would address the clinical questions of interest. When trial evidence is available but not applicable to the clinically relevant target population, we can transport inferences from trial participants to the target population using the trial data and a sample of observational data from the target population. Clinical trial emulations and transportability analyses can be coupled with methods for examining heterogeneity of treatment effects, providing a path toward personalized medicine.
Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Causal inference; emulating clinical trials using observational data; heterogeneity of treatment effects; study design; transportability

Mesh:

Year:  2018        PMID: 29935652     DOI: 10.1016/j.fertnstert.2018.04.005

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Risk of bias in observational studies using routinely collected data of comparative effectiveness research: a meta-research study.

Authors:  Van Thu Nguyen; Mishelle Engleton; Mauricia Davison; Philippe Ravaud; Raphael Porcher; Isabelle Boutron
Journal:  BMC Med       Date:  2021-11-23       Impact factor: 8.775

2.  Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.

Authors:  Janine Bacic; Tao Liu; R Houston Thompson; Stephen A Boorjian; Bradley C Leibovich; Dragan Golijanin; Boris Gershman
Journal:  Urology       Date:  2020-03-04       Impact factor: 2.649

3.  Transradial Access for High-Risk Percutaneous Coronary Intervention: Implications of the Risk-Treatment Paradox.

Authors:  Amit P Amin; Sunil V Rao; Arnold H Seto; Manoj Thangam; Richard G Bach; Samir Pancholy; Ian C Gilchrist; Prashant Kaul; Binita Shah; Mauricio G Cohen; Ty J Gluckman; Anna Bortnick; James T DeVries; Hemant Kulkarni; Frederick A Masoudi
Journal:  Circ Cardiovasc Interv       Date:  2021-07-13       Impact factor: 6.546

4.  Renin, Angiotensin II, and the Journey to Evidence-based Individual Treatment Effects.

Authors:  Jonathan D Casey; Matthew W Semler
Journal:  Am J Respir Crit Care Med       Date:  2020-11-01       Impact factor: 21.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.